Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 15 wrz 2022 · Complete thrombus resolution was achieved in 62.3% (n=99) at a median of 103 days (interquartile range, 32–392 days). 17 Recurrence of thrombus or an increase in LV thrombus area was observed in 14.5% (n=23), a finding associated with poor adherence, prothrombotic conditions, and increased mortality. 17.

    • View EPUB

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Linda S. Williams

      The WEAVE prospective registry (Wingspan Stent System Post...

    • PDF/Epub

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Trial

      Background—The Randomized Evaluation of Long-term...

  2. Among patients with available data on the duration of anticoagulation (n = 67), 59.7% received indefinite therapy, and 40.3% received treatment for varying durations (median 6 months, range 1 to 70 months).

  3. 23 wrz 2022 · If OAC is initiated, a treatment duration might be 13 months, depending on bleeding risk. On the basis of reasonable data and evidence, post-MI patients with LV thrombus should be treated with OAC, typically for a duration of 3 months.

  4. 15 wrz 2022 · Therefore, this American Heart Association scientific statement was commissioned with the goals of addressing 8 key clinical management questions related to LV thrombus, including the prevention and treatment after myocardial infarction, prevention and treatment in dilated cardiomyopathy, management of mural (laminated) thrombus, imaging of LV ...

  5. LV thrombus resolution after 6 months was seen in 92 (79.3%) patients in the warfarin group and 32 (66.6%) patients in the NOAC group (p=0.08). Bleeding rates were similar amongst both groups (8% vs. 10%, p=0.768).

  6. Abstract. One of the potential complications of acute myocardial infarction is left ventricular thrombus (LVT). The incidence of LVT following acute myocardial infarction has decreased dramatically with early invasive reperfusion techniques or fibrinolysis.

  7. Left Ventricular Thrombus Therapy With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248420977567, 26 (3): 233-243, Online publication date: 1-May-2021.